What Is Biomarker Testing? 60 Seconds That Could Change Your CRC Treatment #CRC #BiomarkerTesting

Your colorectal cancer tumor has a unique biological fingerprint — and biomarker testing reads it.
Biomarker testing (also called tumor profiling) analyzes your tumor’s DNA for specific mutations and characteristics — like KRAS, NRAS, BRAF, HER2, and MSI status. These results determine which targeted therapies and immunotherapies may work for YOU. Without testing, you could miss treatments designed specifically for your cancer type.
Yet studies show more than 60% of CRC patients start treatment before getting their biomarker results. That means potentially missing targeted therapies that could be more effective for their specific cancer.
Ask your oncologist about biomarker testing. Know your biomarker — knowing is worth the wait.

👉 Learn more about biomarkers: https://www.knowyourbiomarker.org/
👉 Targeted therapy for CRC: https://www.globalcca.org/learn/colorectal-cancer-targeted-therapy
👉 Know Your Biomarker Treatment Impact at a Glance https://www.knowyourbiomarker.org/biomarker-treatment-impact-overview-table
📊 Source: globalcca.org | knowyourbiomarker.org | Knowing Is Worth The Wait campaign
Subscribe for weekly CRC education from the Global Colon Cancer Association (GCCA). 💙

Видео What Is Biomarker Testing? 60 Seconds That Could Change Your CRC Treatment #CRC #BiomarkerTesting канала Global Colon Cancer Association